Latest Breaking News On - Diabetic eye disease - Page 7 : vimarsana.com

AI screening algorithms to diagnose diabetic retinopathy do not show consistent performance Diabetes continues to be the leading cause of new cases of blindness among adults in the United States. But the current shortage of eye-care providers would make it impossible to keep up with demand to provide the requisite annual screenings for this population. A new study looks at the effectiveness of seven artificial intelligence-based screening algorithms to diagnose diabetic retinopathy, the most common diabetic eye disease leading to vision loss. In a paper published Jan. 5 in Diabetes Care, researchers compared the algorithms against the diagnostic expertise of retina specialists. Five companies produced the tested algorithms - two in the United States (Eyenuk, Retina-AI Health), one in China (Airdoc), one in Portugal (Retmarker), and one in France (OphtAI).

United statesAaron leeStates eyenukEmily hendersonAtlanta va health care systemVeterans affairs puget sound health care systemUniversity of washington school medicineDiabetes careCare systemLead researcherAssistant professorWashington schoolDiabetic eye diseaseEye diseaseArtificial intelligenceDiabetic retinopathy